Safety and immunogenicity of concurrent administration of measles- mumps-rubella-varicella vaccine and PedvaxHIB® vaccines in healthy children twelve to eighteen months old

Pediatric Infectious Disease Journal

Volumn 16, Issue 7, 1997, Pages 662-667

  Reuman, Peter D ^a   Sawyer, Mark H ^b   Kuter, Barbara J ^c   Matthews, Holly ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Concurrent administration; Measles; Mumps; Rubella; Varicella and HIB vaccine

Indexed keywords

CHICKENPOX VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; BACTERIAL INFECTION; CHICKENPOX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECCHYMOSIS; ECZEMA; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MEASLES; MEASLES VIRUS; MULTICENTER STUDY; MUMPS; MUMPS VIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RUBELLA; RUBELLA VIRUS; SUBCUTANEOUS DRUG ADMINISTRATION; VARICELLA ZOSTER VIRUS;

ANTIBODIES, VIRAL; CHICKENPOX VACCINE; HEPATITIS B VACCINES; HUMANS; INFANT; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; RUBELLA VACCINE; VACCINES, COMBINED; VIRAL VACCINES;

EID: 0030858506     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199707000-00008     Document Type: Article

References (16)

1. Robinson CA, Sepe SJ, Lin KF. The president's child immunization initiative: a summary of the problem and the response. Public Health Rep 1993;108:419-25.
2. Robinson CA, Evans WB, Mahanes JA, Sepe SJ. Progress on the childhood immunization initiative. Public Health Rep, 1994;109:594-600.
3. Gershon AA, LaRussa P, Steinberg SP. Live attenuated varicella vaccine: current status and future uses. Semin Pediatr Infect Dis 1991;2:171-7.
4. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella vaccine: efficacy trial in healthy children. N Engl J Med 1984;310:1409-15.
5. Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991;9:643-7.
6. White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991;87:604-10.
7. Bernstein HH, Rothstein EP, Watson BM, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics 1993;92:833-7.
8. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993;91:17-22.
9. Takayama N, Kidokoro M, Suzuki K, Morita M. Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine. Kansenshogaku Zasshi 1992;66:776-80.
10. Dennehy PH, Saracen CL, Peter G. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Pediatrics 1994; 94:514-6.
11. Watson BM, Laufer DS, Kuter BJ, Staehle B, White CJ. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMRV) in healthy children. J Infect Dis 1996;173:731-4.
12. Mulholland EK, Ahonkhai VI, Greenwood AM, et al. Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants. Pediatr Infect Dis J 1993;12:632-7.
13. Shehab ZM, Brunell PA, Cobb E. Epidemiologic standardization of test for susceptibility to mumps. J Infect Dis 1984;149: 810-12.
14. Wasmuth EH, Miller WJ. A sensitive enzyme-linked immunosorbent assay (ELISA) for antibody to varicella-zoster virus (VZV) using purified VZV glycoprotein antigen. J Med Virol 1990;32:189-93.
15. Vella PP, Staub JM, Armstrong J, et al. Immunogenicity of a new Haemophilus Influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB®). Pediatrics 1990;85(Suppl):668-75.
16. White CJ, Kuter BJ, Ngai A, et al. Modified cases of chickenpox after varicella vaccination: coorelation of protection with antibody response. Pediatr Infect Dis J 1992;11:19-23.